The Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended on September 30, 2025, along with the Limited Review Report thereon. ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aayush Wellness reported strong growth for Q2 FY26, with standalone revenue from operations jumping to ₹3,991.22 lakhs from ₹1,427.83 lakhs in Q2 FY25 — roughly 180% year-on-year growth. Total income for the quarter stood at ₹4,056.47 lakhs. Standalone profit after tax rose about 31% to ₹121.35 lakhs (vs ₹92.28 lakhs), while EPS was ₹0.25 versus ₹0.28 last year (lower due to share base expansion). For the half-year (H1 FY26), revenue surged to ₹6,254.34 lakhs from ₹2,536.05 lakhs, with PAT more than doubling to ₹237.02 lakhs from ₹117.78 lakhs. The auditor (AJMS & Co LLP) issued an unqualified limited review report with no qualifications. Notably, the company formed three new wholly-owned subsidiaries during the period — Aayush Labs Pvt Ltd, Aayush Ventures Pvt Ltd (both in India), and Aayush International Pte Ltd in Singapore — to support expansion in wellness and Southeast Asian markets. Borrowings rose sharply from ₹4.53 lakhs to ₹515.53 lakhs (consolidated), likely to fund this expansion.
Strong top-line and profit growth signal positive momentum for the company and should be well-received by shareholders. However, the sharp rise in borrowings and the divergence between standalone (negative operating cash flow of ₹121.87 lakhs) and consolidated numbers warrant a closer look at cash quality and the capital structure going forward.